Skip to main content
Equibles
CAPR logo

CAPR · Capricor Therapeutics, Inc. · Metrics

Track CAPR — free

Use CAPR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CAPR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$6.60 -0.05 (-0.68%)
Russell 2000 member Rebalance outlook locked
Market Cap
$384.30M
Shares
58.14M
Volume · Oct 20 2M Avg daily vol (3M) 7M

CAPR metrics

75 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$6.65
Market cap
$386.33M

Price action

20 metrics
Price change (1W)
-11.0%
Price change (30D)
-25.3%
Price change (3M)
-65.9%
Price change (6M)
-80.6%
Price change (YTD)
-77.0%
Price change (1Y)
+6.4%
Trailing year
Price change (5Y)
+67.9%
52-week high
$35.34
52-week low
$3.85
Change from 52-week high
-81.2%
Change from 52-week low
+72.7%
Annualized volatility
395.4%
Annualized volatility (3M)
216.8%
Beta
1.3
RSI (14D)
36.9
Price vs SMA 50
-16.7%
Price vs SMA 200
-69.3%
Avg volume (3M)
7.00M
Relative volume
0.3
Average dollar volume
$51.87M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
58.14M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
17.3×
reciprocal yield 5.8%
P / book
1.6
reciprocal yield 63.7%
FCF yield
-29.7%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-33.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
10.3×
reciprocal yield 9.7%
EV / revenue historical average (5Y)
110.1×
reciprocal yield 0.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$135.16M
Net income (TTM)
−$129.42M
Trailing 12 months
Diluted EPS (TTM)
$-2.45
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-2.55
EBITDA per diluted share (TTM)
$-2.51
Net income per diluted share (TTM)
$-2.45
Operating cash flow per diluted share (TTM)
$-1.97
Free cash flow per diluted share (TTM)
$-2.16
Capital expenditures per diluted share (TTM)
$0.19
R&D per diluted share (TTM)
$1.89
Stock compensation per diluted share (TTM)
—
Book value per share
$5.33

Growth

11 metrics
Revenue growth YoY
-7.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$22.27M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+26.7%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-52.6%
Return on assets
-35.1%
Debt / equity
0.0
Current ratio
7.3
EBITDA (TTM)
−$133.07M
Free cash flow (TTM)
−$114.90M
Quick ratio
7.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$20.94M
Latest balance sheet
Cash & equivalents
$20.94M
Total assets
$368.74M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$104.00M
Capital expenditures (TTM)
$10.91M
R&D (TTM)
$99.73M
SG&A (TTM)
—
Stock compensation (TTM)
$9.77M
R&D / revenue
—
Stock compensation / revenue
43.8%

Ownership (13F)

9 metrics
13F filers
176
13F filer change QoQ
-5
Institutional ownership
79.0%
Conviction holders (share of 13F filers)
1.8%
Crowding (high-turnover and private-fund holders)
25.1%
Private-fund adviser ownership
22.7%
Active holders' share change QoQ
+8.1%
Holder tenure
8.0
Price vs estimated holder cost
+13.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
14.8%

Short interest

3 metrics
Short interest
32.4%
Latest settlement · 4.5 days to cover
Days to cover
4.5d
Short-squeeze score
72 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1133869 CUSIP 14070B309 13F (30d) 9 filings 9 filers Visit website Investor relations